Virtual pharma companies (VPCs) account for a growing percentage of the pharmaceutical market. With few internal resources and limited knowledge and expertise regarding regulatory expectations across drug development and commercialization activities, VPCs rely heavily on outsourcing partners. To maximize the benefits of outsourcing, however, they must choose the right partners.  Tedor Pharma Services does not … Continued